Role of Stem Cells in Human Uterine Leiomyoma Growth
Open accessThe DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Uterine leiomyoma is the most common benign tumor in reproductive-age women. Each leiomyoma is thought to be a benign monoclonal tumor arising from a single transformed myometrial smooth muscle cell; however, it is not known what leiomyoma cell type is responsible for tumor growth. Thus, we tested the hypothesis that a distinct stem/reservoir cell-enriched population, designated as the leiomyoma-derived side population (LMSP), is responsible for cell proliferation and tumor growth. PRINCIPAL FINDINGS: LMSP comprised approximately 1% of all leiomyoma and 2% of all myometrium-derived cells. All LMSP and leiomyoma-derived main population (LMMP) but none of the side or main population cells isolated from adjacent myometrium carried a mediator complex subunit 12 mutation, a genetic marker of neoplastic transformation. Messenger RNA levels for estrogen receptor-α, progesterone receptor and smooth muscle cell markers were barely detectable and significantly lower in the LMSP compared with the LMMP. LMSP alone did not attach or survive in monolayer culture in the presence or absence of estradiol and progestin, whereas LMMP readily grew under these conditions. LMSP did attach and survive when directly mixed with unsorted myometrial cells in monolayer culture. After resorting and reculturing, LMSP gained full potential of proliferation. Intriguingly, xenografts comprised of LMSP and unsorted myometrial smooth muscle cells grew into relatively large tumors (3.67 ± 1.07 mm(3)), whereas xenografts comprised of LMMP and unsorted myometrial smooth muscle cells produced smaller tumors (0.54 ± 0.20 mm(3), p<0.05, n = 10 paired patient samples). LMSP xenografts displayed significantly higher proliferative activity compared with LMMP xenografts (p<0.05). CONCLUSIONS: Our data suggest that LMSP, which have stem/reservoir cell characteristics, are necessary for in vivo growth of leiomyoma xenograft tumors. Lower estrogen and progesterone receptor levels in LMSP suggests an indirect paracrine effect of steroid hormones on stem cells via the mature neighboring cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For the stimulation of clonal expansion and growth of leiomyoma, sex steroids and steroid hormone receptors are necessary; yet, leiomyoma stem cells express barely detectable levels of ESR1 or PGR (Mas et al., 2012;Ono et al., 2012).”
From Endometriosis and nuclear receptors (2019) · cites this paper as Ono et al., 2012
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The relationship between the spleen colony-forming cell and the haemopoietic stem cell.
Schofield, R. (1978) · PubMed · Cited by 2,333
Tie2/Angiopoietin-1 Signaling Regulates Hematopoietic Stem Cell Quiescence in the Bone Marrow Niche
Arai, F., Hirao, A., Ohmura, M., Sato, H., Matsuoka, S., Takubo, K., Ito, K., Koh, G. Y., & Suda, T. (2004) · Cell · doi:10.1016/j.cell.2004.07.004 · Cited by 1,974
Jordan, C. T., Guzman, M. L., & Noble, M. (2006) · New England Journal of Medicine · doi:10.1056/nejmra061808 · Cited by 1,702
Stewart, E. A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)03622-9 · Cited by 1,031
Etiology, symptomatology, and diagnosis of uterine myomas
Parker, W. H. (2007) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.01.093 · Cited by 721 · cited 1×
“Several recurrent genetic aberrations, such as trisomy of chromosome 12, deletions in 7q, and mutation affecting the mediator complex subunit 12 (MED12) or the high mobility group AT-hook 2 (HMGA2) gene were reported in uterine leiomyomas [15,16,17,18].”
BackgroundControl of mammary stem cell function by steroid hormone signalling
Asselin-Labat, M.-L., Vaillant, F., Sheridan, J. M., Pal, B., Wu, D., Simpson, E. R., Yasuda, H., Smyth, G. K., Martin, T. J., Lindeman, G. J., et al. (2010) · Nature · doi:10.1038/nature09027 · Cited by 693 · cited 1×
“In mammary structures of humans and mice, mammary stem cells, despite being void of ESR1 and PGR themselves, are subject to regulation in both number and repopulating ability by steroid hormones, particularly progesterone [40,41,42,43].”
BackgroundProgesterone induces adult mammary stem cell expansion
Joshi, P. A., Jackson, H. W., Beristain, A. G., Di Grappa, M. A., Mote, P. A., Clarke, C. L., Stingl, J., Waterhouse, P. D., & Khokha, R. (2010) · Nature · doi:10.1038/nature09091 · Cited by 689 · cited 1×
“In mammary structures of humans and mice, mammary stem cells, despite being void of ESR1 and PGR themselves, are subject to regulation in both number and repopulating ability by steroid hormones, particularly progesterone [40,41,42,43].”
BackgroundMED12 , the Mediator Complex Subunit 12 Gene, Is Mutated at High Frequency in Uterine Leiomyomas
Mäkinen, N., Mehine, M., Tolvanen, J., Kaasinen, E., Li, Y., Lehtonen, H. J., Gentile, M., Yan, J., Enge, M., Taipale, M., et al. (2011) · Science · doi:10.1126/science.1208930 · Cited by 658 · cited 3×
“MED12 mutations demonstrate that LMSP are committed to a leiomyoma cell lineage Recently, mutations in the MED12 gene have been reported in the majority of leiomyoma tissues and cells [16].”
BackgroundUterine Fibroids: The Elephant in the Room
Walker, C. L., & Stewart, E. A. (2005) · Science · doi:10.1126/science.1112063 · Cited by 547 · cited 1×
“Uterine leiomyomas, the most common pelvic tumor in women, are benign smooth muscle tumors originating from the myometrium”
BackgroundUterine Myomas: An Overview of Development, Clinical Features, and Management
Wallach, E. E., & Vlahos, N. F. (2004) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000136079.62513.39 · Cited by 540 · cited 2×
“Uterine leiomyomas are also an important cause of infertility and they are the most common medical reason for hysterectomy [3,4].”
Background
Cited by
Items 101–141 of 141
Etiology, Pathogenesis, and Malignant Potential of Uterine Leiomyoma – A Review
Hauptmann, S., & Köhler, G. (2014) · Current Obstetrics and Gynecology Reports · doi:10.1007/s13669-014-0091-x · Cited by 8
“In vivo experiments have shown that LMSP cells themselves are mitotically quiescent but have the same MED12 mutation as the smooth muscle cells of LM [32].”
BackgroundKhan, Z., & Stewart, E. A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-47912-7.00026-3 · Cited by 7
The role of stem cells in benign tumors
Qin, H., Bao, D., Tong, X., Hu, Q., Sun, G., & Huang, X. (2016) · Tumor Biology · doi:10.1007/s13277-016-5370-x · Cited by 6
“Similarly, inhibition of Wnt signaling by depletion of Tcf4 or β-catenin led to significant suppression of epithelium proliferation [19, 20].”
BackgroundBarron, L., Khadka, S., Schenken, R. S., He, L., Blenis, J., Blagg, J., Chen, S.-F., Tsai, K., & Boyer, T. (2021) · F&S Science · doi:10.1016/j.xfss.2021.09.003 · Cited by 7
Herbal Medicine in Uterine Fibroid
Li, Z.-L., Huang, T.-Y., Ho, Y., Shih, Y.-J., Chen, Y., Tang, H., Lin, H., Whang-Peng, J., & Wang, K. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.94101 · Cited by 8
Pivotal Role of Ubiquitin Carboxyl-Terminal Hydrolase L1 (UCHL1) in Uterine Leiomyoma
Suzuki, T., Dai, Y., Ono, M., Kojima, J., Sasaki, T., Fujiwara, H., Kuji, N., & Nishi, H. (2023) · Biomolecules · doi:10.3390/biom13020193 · Cited by 6
Self-citationPathophysiology of Uterine Fibroids
Otify, M., & Critchley, H. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108332798.002 · Cited by 5
Takao, T., Ono, M., Yoshimasa, Y., Masuda, H., & Maruyama, T. (2022) · F&S Science · doi:10.1016/j.xfss.2022.04.002 · Cited by 6
Self-citationEpigenetics and Uterine Fibroids
Maekawa, R., & Sugino, N. (2018) · Comprehensive gynecology and obstetrics · doi:10.1007/978-981-10-7167-6_5 · Cited by 4
Modern view on the pathogenesis of proliferative diseases of the uterus
Баженова, Л. Г., Shramko, S. V., Sabantsev, M. A., & Gulyaeva, L. F. (2018) · Russian Bulletin of Obstetrician-Gynecologist · doi:10.17116/rosakush20181806131 · Cited by 5
Characterization of m6A Modifiers and RNA Modifications in Uterine Fibroids
George, J. W., Cancino, R. A., Miller, J. L. G., Qiu, F., Lin, Q., Rowley, M. J., Chennathukuzhi, V. M., & Davis, J. S. (2024) · Endocrinology · doi:10.1210/endocr/bqae074 · Cited by 3
Simón, C. (2014) · Fertility and Sterility · doi:10.1016/j.fertnstert.2014.07.1210 · Cited by 4
Britten, J., Malik, M., Pekny, C. J., DeAngelis, A., & Catherino, W. H. (2020) · F&S Science · doi:10.1016/j.xfss.2020.09.003 · Cited by 3
Vincenzo, M. D., Quattro, C. D., Rossato, M., Lazzarini, R., Carpini, G. D., Ciavattini, A., & Orciani, M. (2022) · Genes · doi:10.3390/genes13071106 · Cited by 3
“Epigenetic mechanisms, gene mutations, chronic inflammation, disrupted controls in progenitor cells, and dysregulation of miRNAs have been all evaluated as potential causes; however, their aetiology has not been fully clarified, [2,3].”
BackgroundUterine myoma: еtiology and morphogenesis
Косей, Н. В. (2018) · Reproductive Endocrinology · doi:10.18370/2309-4117.2018.40.23-32 · Cited by 3
Avaliação de tratamentos alternativos no controle das infertilidades uterinas em bovinos
Ribeiro, B. L. M. (2019) · doi:10.11606/t.10.2019.tde-27092019-115735 · Cited by 3
Larraín, D., & Prado, J. (2024) · IntechOpen eBooks · doi:10.5772/intechopen.1002969 · Cited by 6
A Systematic Review on Uterine Leiomyoma: From Pathogenomics to Therapeutics
Narwal, S., Vashist, M., Kaushik, R., Kalra, V., Hooda, R., & Singh, S. (2024) · IntechOpen eBooks · doi:10.5772/intechopen.1002877 · Cited by 4
Sokolov, B., Berbets, A. M., Kant, S., & Yuzko, O. M. (2024) · Cell and Organ Transplantology · doi:10.22494/cot.v12i1.161 · Cited by 2
Pathogenesis, Classification, Histopathology, and Symptomatology of Fibroids
Tinelli, A., Resta, L., Sparić, R., Stefanović, A., & Malvası, A. (2017) · Springer eBooks · doi:10.1007/978-3-319-58780-6_1 · Cited by 2
Dovletkhanova, E. R., Mezhevitinova, E. A., & Prilepskaya, V. N. (2019) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2019-7-13-20 · Cited by 2
“Улипристала ацетат (Эсмия®, Gedeon Richter) – селективный модулятор прогестероновых рецепторов, обладает смешанными агонистическими-антагонистическими свойствами, оказывает антипролиферативный, антифиброзный эффекты, индуцирует апоптоз в клетках миоматозного узла, не влияя на здоровый миометрий [6, 27].”
Uterine fibroids: a look at the problem
Karamyan, R. A., Ordiyants, I. M., Khorolsky, V. A., & Asatryan, D. R. (2022) · Medical Herald of the South of Russia · doi:10.21886/2219-8075-2022-13-2-18-25 · Cited by 6
“Также было обнаружено, что у этих клеток низкая концентрация рецепторов к прогестерону и эстрогену [10].”
Koltsova, A. S., Efimova, O. A., Баранов, В. С., Yarmolinskaya, M. I., Polenov, N. I., & Pendina, A. A. (2023) · Ecological genetics · doi:10.17816/ecogen606642 · Cited by 2
Genetic and Genomics of Uterine Myomas
Vergara, D., & Gréco, M. (2014) · Springer eBooks · doi:10.1007/978-3-319-10305-1_2 · Cited by 2
Vitamin D and Uterine Fibroids: Insights into Pathophysiology and Therapeutic Potential
Ciebiera, M., Zarychta, E., Żeber‐Lubecka, N., Zgliczyńska, M., Włodarczyk, M., Massalska, D., Corachán, A., Ali, M., Madueke-Laveaux, O. S., & Al-Hendy, A. (2026) · Endocrine Reviews · doi:10.1210/endrev/bnaf043 · Cited by 3
Uterin leiomyomda Wnt, β-katenin, TGF–β, Siklin D1’in Ekspresyon seviyelerinin belirlenmesi
Pençe, H. H., Karuserci, Ö. K., TANOĞLU, E. G., & Uğur, M. G. (2019) · Zeynep Kamil Tıp Bülteni · doi:10.16948/zktipb.629373 · Cited by 1
MED12: A NOVEL PLAYER IN UTERINE LEIOMYOMAS
Mäkinen, N. (2015) · Helda - University of Helsinki Institutional Repository · Cited by 1
Garcia, N. (2015) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2015.tde-12052015-105036
The role of mediator complex subunit 12 (MED12) in the murine reproductive tract
Mittal, P. (2015) · D-Scholarship@Pitt (University of Pittsburgh) · doi:10.13140/rg.2.2.20308.60809
Stem Cells and Uterine Fibroids
Ono, M., Maruyama, T., Fujiwara, H., & Bulun, S. E. (2018) · Comprehensive gynecology and obstetrics · doi:10.1007/978-981-10-7167-6_4
Self-citationMolecular Pathogenesis of Uterine Fibroids
Kimura, F., Tsuji, S., & Murakami, T. (2018) · Comprehensive gynecology and obstetrics · doi:10.1007/978-981-10-7167-6_3 · Cited by 1
Moravek, M. B., & Bulun, S. E. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00131-1
Self-citationA Role for k-Ras in Uterine Leiomyoma
Maduro, M. R. (2017) · Reproductive Sciences · doi:10.1177/1933719117731645
“While genetic susceptibility and environmental exposures are known to play a role in uterine leiomyoma, alterations in primitive myometrial stem cells affected by ovarian hormones have been suggested to be involved in the disease.(1-3) Given the complexity of uterine leiomyoma formation, many studies have recently foc…”
BackgroundVafaei, S. (2023) · Cancer Studies and Molecular Medicine - Open Journal · doi:10.17140/csmmoj-8-136
Stem Cell Therapy in Obstetrics and Gynecology
Comparetto, C., & Borruto, F. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15717-2.00076-7
Sokolov, B. (2024) · Актуальні питання педіатрії акушерства та гінекології · doi:10.11603/24116-4944.2024.1.14658
ANALYSIS OF FACTORS INFLUENCING TREATMENT OUTCOMES OF UTERINE SARCOMAS
Davydiuk, S., & Kryzhanivska, A. (2025) · Experimental Oncology · doi:10.15407/exp-oncology.2025.01.083
Ribeiro, B. L. M., Fülber, J., Alemán, M. A. R., Pfeifer, L. F. M., Andrade, J. D. S., Moreira, E. M., de Silva, R. R., Baccarin, R. Y. A., de Sá, L. R. M., Li, J., et al. (2026) · Stem Cells International · doi:10.1155/sci/8863818
Mikhaleva, L., Orazov, M. R., Dolgov, E. D., Александрович, М. С., Владиславовна, Г. З., Shakhpazyan, N. K., Pechnikova, V. V., & Gushchin, M. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27052376
“Uterine leiomyoma (UL), also known as uterine fibroids (UFs), is the most common benign monoclonal well-circumscribed tumor of the uterine body and cervix, originating from myometrial smooth muscle cells (progenitor/stem cells) [22,23].”
Vázquez, P., Salas, A., Beltrán-Flores, S., de Oca, F. M., Delgado, A., & Almeida, T. A. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1804196 · Cited by 1
Metadata
- Authors
- Ono, M., Qiang, W., Serna, V. A., Yin, P., Coon, J. S., Navarro, A., Monsivais, D., Kakinuma, T., Dyson, M., Druschitz, S., Unno, K., Kurita, T., & Bulun, S. E.
- Affiliations
- Northwestern University (US)
- Corresponding author
- Bulun, Serdar E.
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-05-03
- Volume
- 7
- Issue
- 5
- Pages
- e36935
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3343011
- OpenAlex
- W2046521626
- Semantic Scholar
- 546a83c8bc3366b826a6171706241d9b4ac6c215
- Cited by
- 141
- References
- 45
- Citations by year
- 2026: 4 · 2025: 2 · 2024: 7 · 2023: 11 · 2022: 9 · 2021: 9 · 2020: 14 · 2019: 9 · 2018: 16 · 2017: 9 · 2016: 10 · 2015: 15 · 2014: 16 · 2013: 10
- FWCI
- 15.82
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Northwestern University (CA060553, NCI CA060553)
- National Institutes of Health (CA-060553, NCI CA060553)
- National Cancer Institute (CA 060553, NCI CA060553, R01CA154358, P30CA060553)
- National Institute of General Medical Sciences (R25GM079300)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (P01HD057877, R01HD064402)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Uterine Myomas and Treatments
- Health Sciences › Medicine › Urology › Urologic and reproductive health conditions
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Keywords
- uterine fibroids, stem cells, side population cells, tumor growth, myometrium, estrogen receptor alpha, progesterone receptor, smooth muscle cells, xenografts, steroid hormone signaling, paracrine effects, oncogenic transformation
- MeSH terms
- Adult, Animals, Antigens, Surface, Base Sequence, Blood Cells, Bone Marrow Cells, Cell Cycle, Cell Differentiation, Cell Transformation, Neoplastic, Female, Humans, Leiomyoma, Middle Aged, Mutation, Myometrium, Neoplastic Stem Cells, Uterine Neoplasms, Mice, SCID, Mice, Inbred NOD, Coculture Techniques, Cell Lineage, Myocytes, Smooth Muscle, Cell Proliferation, Mice, Mediator Complex, Mesenchymal Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.